04.08.2017

Legal base: Article 17 (1) MAR - confidential information.

The Management Board of Synthos S.A. ('Company') informs that as a result of a review of the major assumptions for the effects of activity involving Company's assets acquired in 2016 from INEOS Group, there may occur a risk of their impairment.

With regards to the foregoing, the Company will immediately conduct impairment tests covering these assets, i.e. by 11 August 2017. The Company will inform about the results by means of a separate Current Report.

Legal base: Article 17 (1) MAR (Regulation of the European Parliament and the Council EU No. 596/2014 of 16 April 2014 on market abuse (Regulation on market abuse) and repealing Directive 2003/6/EC of the European Parliament and the Council Directive 2003/124/EC, 2003/125/EC and 2004/72/EC (Official Journal of the European Union of 12 June 2014, No. L 173/1)

Synthos SA published this content on 04 August 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 04 August 2017 12:39:16 UTC.

Original documenthttp://synthosgroup.com/en/investors/current-reports/article/raport-biezacy-nr-17-3304/

Public permalinkhttp://www.publicnow.com/view/F24292235CE67524BBEBD642235693091C94294D